JP2022521818A5 - - Google Patents
Info
- Publication number
- JP2022521818A5 JP2022521818A5 JP2021557342A JP2021557342A JP2022521818A5 JP 2022521818 A5 JP2022521818 A5 JP 2022521818A5 JP 2021557342 A JP2021557342 A JP 2021557342A JP 2021557342 A JP2021557342 A JP 2021557342A JP 2022521818 A5 JP2022521818 A5 JP 2022521818A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- optionally substituted
- compound
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962823374P | 2019-03-25 | 2019-03-25 | |
| US62/823,374 | 2019-03-25 | ||
| US201962874773P | 2019-07-16 | 2019-07-16 | |
| US62/874,773 | 2019-07-16 | ||
| PCT/US2020/024654 WO2020198323A1 (en) | 2019-03-25 | 2020-03-25 | Prmt5 inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022521818A JP2022521818A (ja) | 2022-04-12 |
| JP2022521818A5 true JP2022521818A5 (cg-RX-API-DMAC7.html) | 2023-04-03 |
| JP7609798B2 JP7609798B2 (ja) | 2025-01-07 |
Family
ID=72609147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557342A Active JP7609798B2 (ja) | 2019-03-25 | 2020-03-25 | Prmt5インヒビター及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12583859B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3947387B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7609798B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220023330A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114127072B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020245480A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021019125A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3134779A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL318073A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021011524A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202110272SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020198323A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11077101B1 (en) | 2018-07-18 | 2021-08-03 | Tango Therapeutics, Inc. | Compounds and methods of use |
| EP3947387B1 (en) | 2019-03-25 | 2024-10-23 | California Institute Of Technology | Prmt5 inhibitors and uses thereof |
| US12403137B2 (en) | 2019-10-28 | 2025-09-02 | Tango Therapeutics, Inc. | Compounds and methods of use |
| CN116568677B (zh) | 2020-07-31 | 2026-07-28 | 探戈医药股份有限公司 | 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物 |
| CN117157297B (zh) * | 2021-07-20 | 2026-06-16 | 上海齐鲁制药研究中心有限公司 | Prmt5抑制剂 |
| WO2023127857A1 (ja) * | 2021-12-27 | 2023-07-06 | 株式会社理研ジェネシス | 新規人工核酸、その製造方法及び用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6143749A (en) | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
| US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
| CA2903394C (en) * | 2013-03-14 | 2021-08-31 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| EA031895B1 (ru) | 2015-02-24 | 2019-03-29 | Пфайзер Инк. | Замещенные нуклеозидные производные, полезные в качестве агентов против рака |
| TWI730980B (zh) * | 2015-08-26 | 2021-06-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| CN108884108B (zh) * | 2016-03-10 | 2021-08-31 | 詹森药业有限公司 | 用于用作prmt5抑制剂的取代核苷类似物 |
| CA2969295A1 (en) | 2016-06-06 | 2017-12-06 | Pfizer Inc. | Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor |
| WO2018065365A1 (en) * | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018160824A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| MA49840A (fr) * | 2017-08-09 | 2020-06-17 | Prelude Therapeutics Inc | Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5) |
| MX2020005944A (es) * | 2017-12-08 | 2020-08-24 | Janssen Pharmaceutica Nv | Analogos espirobiciclicos novedosos. |
| EP3947387B1 (en) | 2019-03-25 | 2024-10-23 | California Institute Of Technology | Prmt5 inhibitors and uses thereof |
-
2020
- 2020-03-25 EP EP20778402.6A patent/EP3947387B1/en active Active
- 2020-03-25 BR BR112021019125A patent/BR112021019125A2/pt not_active IP Right Cessation
- 2020-03-25 KR KR1020217034437A patent/KR20220023330A/ko not_active Ceased
- 2020-03-25 MX MX2021011524A patent/MX2021011524A/es unknown
- 2020-03-25 JP JP2021557342A patent/JP7609798B2/ja active Active
- 2020-03-25 CA CA3134779A patent/CA3134779A1/en active Pending
- 2020-03-25 WO PCT/US2020/024654 patent/WO2020198323A1/en not_active Ceased
- 2020-03-25 IL IL318073A patent/IL318073A/en unknown
- 2020-03-25 SG SG11202110272SA patent/SG11202110272SA/en unknown
- 2020-03-25 AU AU2020245480A patent/AU2020245480A1/en not_active Abandoned
- 2020-03-25 US US17/598,152 patent/US12583859B2/en active Active
- 2020-03-25 CN CN202080037608.5A patent/CN114127072B/zh active Active
-
2021
- 2021-09-23 IL IL286622A patent/IL286622A/en unknown